- Home
- SRBK vs ANIX Comparison
SRBK vs ANIX Comparison
Compare SRBK & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$2.88
Company Overview
Basic Information| Metric | SRBK | ANIX |
|---|---|---|
| Founded | 1887 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.7M | 104.0M |
| IPO Year | 2023 | 2013 |
Fundamental Metrics
Financial Performance| Metric | SRBK | ANIX |
|---|---|---|
| Price | $16.87 | $2.88 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 31.2K | ★ 95.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.19% | N/A |
| EPS Growth | ★ 138.36 | 12.82 |
| EPS | ★ 0.20 | N/A |
| Revenue | N/A | ★ $210,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $84.00 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.38 | $2.33 |
| 52 Week High | $18.04 | $5.46 |
Technical Indicators
Market Signals| Indicator | SRBK | ANIX |
|---|---|---|
| Relative Strength Index (RSI) | 50.26 | 45.57 |
| Support Level | $14.41 | $2.74 |
| Resistance Level | $17.14 | $3.11 |
| Average True Range (ATR) | 0.44 | 0.16 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 69.09 | 35.00 |
Price Performance
Historical Comparison SRBK
ANIX
About SRBK SR Bancorp Inc.
SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.